Dxcover Competitors and Similar CompaniesClear all

Dxcover's competitors and similar companies include Arrogene, Guardant Health and KEW.
Dxcover
Dxcover
Dxcover (previously known as ClinSpec Diagnostics) is advancing a blood test that can provide accurate results and potentially improve brain cancer survival rates through earlier detection.
Arrogene
Arrogene
Arrogene is a development stage company that develops nano-biopolymers and related technologies for cancer therapeutics and diagnostics.
Guardant Health
Guardant Health
Guardant Health is a company that specializes in non-invasive cancer diagnostics and comprehensive genomic liquid biopsy.
KEW
KEW
KEW is a genomic profiling company specializing in cancer care.
Founding Date
Founding Date
2016
Founding Date
2007
Founding Date
2012
Founding Date
2011
Type
Type
Private
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
Glasgow, GB HQ
Locations
West Hollywood, US HQ
Locations
Redwood City, US HQ
Locations
Waltham, US HQ
Newton, US
Employees
Employees
294% increase
Employees
N/A
Employees
1,7681% decrease
Employees
205% increase

Financial

Net income
Net income
N/A
Net income
($1m) (FY, 2015)
Net income
($416.3m) (FY, 2025)
Net income
N/A

Funding

Latest funding round
Latest funding round
$ 1.5m (over 5 years ago)
Latest funding round
$ 750k (over 10 years ago)
Latest funding round
N/A
Latest funding round
$ 16.8m (over 11 years ago)
Total funding raised
Total funding raised
$ 6.3m
Total funding raised
$ 3.7m
Total funding raised
$ 550m
Total funding raised
$ 32.9m
For sources of this data, please see the company profile

View Company Profiles

Arrogene
HQ
West Hollywood, US

Arrogene is a development stage company that develops nano-biopolymers and related technologies for cancer therapeutics and diagnostics.

View company
Guardant Health
HQ
Redwood City, US
Employees
1,768↓ 1% decrease

Guardant Health is a company that specializes in non-invasive cancer diagnostics and comprehensive genomic liquid biopsy.

View company
KEW
HQ
Waltham, US
Employees
20↑ 5% increase

KEW is a genomic profiling company specializing in cancer care.

View company